About Mobix Labs, Inc.
At Mobix Labs, we’re committed to transforming connectivity by partnering closely with our customers to deliver advanced semiconductor and wireless systems solutions tailored to their needs. Based in Irvine, California, we specialize in four key areas; EMI Interconnect Solutions for secure aerospace and GPS systems, Active Optical Cables (AOC) for high-speed AI datacenter interconnects, 5G IC Solutions for mmWave communications, and Wireless Systems Solutions, including joint design and manufacturing services for RF technologies, serving customers in 5G, radar, and imaging sensors. Through deep collaboration and innovation, we’re shaping the future of connectivity. Visit mobixlabs.com and follow us on LinkedIn.
Mobix Labs, the logo, and SMART™ Edge Device are among the trademarks of Mobix Labs. Other trademarks are the property of their respective owners.
Note Regarding Customer Pipeline Statistic
“Customer pipeline” reflects estimated potential future business based on interest expressed by potential customers for qualified programs, stated in terms of estimated revenue that may be realized in one or more future periods. All customer pipeline information constitutes forward-looking statements. Customer pipeline is not a proxy for backlog or an estimate of future revenue, nor should it be considered as any other measure or indicator of financial performance. Rather, Mobix Labs uses customer pipeline as a statistical metric to indicate the company’s current view of relative changes in future potential business across various end markets. Time horizons vary accordingly, based on product type and application. Actual business realized depends on ultimate customer selection, program share, strategic decisions based on expected revenue, margin and other factors discussed below under “Forward-Looking Information.”
Forward-looking Information
This press release and the related earnings call contain “forward-looking statements” regarding the intent, beliefs or current expectations of the Company for purposes of the federal securities laws. These forward-looking statements include, but are not limited to, statements regarding Mobix Labs, Inc. and Mobix Labs, Inc.’s management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would,” “poised” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this presentation and discussion may include, for example, statements about (i) our expectations regarding customer demand and requests for proposals as well as our ability to expand our customer base and product offerings; (ii) our financial outlook, including expectations regarding revenue growth, adjusted gross margin and adjusted operating margin; (iii) our ability to secure additional financing and any strategic initiatives, specifically with respect to synergistic product acquisitions; (iv) our expectations regarding our intent to acquire J-Mark Connectors Inc. and any other possible acquisitions; (v) our expectations regarding future market conditions and the growth of the market, including our expectations regarding the serviceable addressable market; (vi) any future product enhancements or developments as well as customer reception of our products; (vii) our ability to secure additional orders, including in connection with the U.S. defense program; (viii) the impact of any strategic partnerships on our business. These forward-looking statements are based on information available as of the date of this presentation and discussion, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we undertake no obligations to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. In addition, these forward-looking statements and the information in this press release and the earnings call are qualified in their entirety by cautionary statements and risk factor disclosures contained in the Company’s Securities and Exchange Commission (“SEC”) filings, including the Company’s Registration Statement on Form S-1 filed on August 12, 2024, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 and any subsequent SEC filings. All forward-looking statements in this press release are based on information available to us on the date hereof, and we assume no obligation to update such statements.
As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include (i) the risk that the price of our securities may be volatile due to a variety of factors, including changes in the highly competitive industries in which we operate, variations in performance across competitors, changes in laws, regulations, technologies, the global supply chain, and macro-economic and social environments affecting our business; (ii) our ability to regain compliance and maintain our listing of securities on Nasdaq; (iii) the risks concerning our ability to continue as a going concern; (iv) the inability to meet future capital requirements and risks related to our ability to raise additional capital including potential dilution to our stockholders; (v) the risk that we are unable to successfully commercialize our products and solutions, or experience significant delays in doing so; (vi) the risk that we may not be able to generate income from operations in the foreseeable future; (vii) the risk that we experience difficulties in managing our growth and expanding operations; (viii) the risk that we may not be able to consummate planned strategic acquisitions, or fully realize anticipated benefits or capture synergies from past or future acquisitions or investments; (ix) the risk that we may be unable to successfully defend ourselves in ongoing litigation or that additional actions may be commenced against us; (x) the risk that our patent applications may not be approved or may take longer than expected, and we may incur substantial costs in enforcing and protecting our intellectual property; (xi) the risk of being an early stage company and that our limited operating history may make it difficult to evaluate our future prospects and the risks and challenges that we may encounter; (xii) the risk that we cannot predict whether we will maintain revenue growth; (xiii) the risk that the markets for our semiconductor products and solutions are highly competitive; (xiv) the risk that future sales of our Class A Common Stock may cause the market price of our Class A Common Stock to drop significantly, even if our business is doing well; and (xv) inflation and unfavorable global economic conditions could adversely affect our business.
Mobix Labs, Inc. | ||||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Loss | ||||||||||||||||
(unaudited, in thousands, except share and per share amounts) | ||||||||||||||||
Three months ended June 30, | Nine months ended June 30, | |||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Net revenue | $ |
2,058 |
|
$ |
80 |
|
$ |
3,488 |
|
$ |
791 |
|
||||
Costs and expenses | ||||||||||||||||
Cost of revenue |
|
1,327 |
|
|
285 |
|
|
2,608 |
|
|
1,188 |
|
||||
Research and development |
|
1,369 |
|
|
3,159 |
|
|
4,328 |
|
|
9,209 |
|
||||
Selling, general and administrative |
|
8,710 |
|
|
6,375 |
|
|
31,731 |
|
|
21,198 |
|
||||
Loss from operations |
|
(9,348 |
) |
|
(9,739 |
) |
|
(35,179 |
) |
|
(30,804 |
) |
||||
Interest expense |
|
127 |
|
|
309 |
|
|
1,232 |
|
|
1,186 |
|
||||
Change in fair value of earnout liability |
|
(661 |
) |
|
- |
|
|
(30,599 |
) |
|
- |
|
||||
Change in fair value of PIPE make-whole liability |
|
310 |
|
|
- |
|
|
(122 |
) |
|
- |
|
||||
Change in fair value of private warrants |
|
(68 |
) |
|
- |
|
|
412 |
|
|
- |
|
||||
Change in fair value of SAFEs |
|
- |
|
|
(30 |
) |
|
10 |
|
|
528 |
|
||||
Merger-related transaction costs expensed |
|
- |
|
|
- |
|
|
4,009 |
|
|
- |
|
||||
Other non-operating losses, net |
|
128 |
|
|
- |
|
|
1,177 |
|
|
- |
|
||||
Loss before income taxes |
|
(9,184 |
) |
|
(10,018 |
) |
|
(11,298 |
) |
|
(32,518 |
) |
||||
Provision (benefit) for income taxes |
|
(1,505 |
) |
|
(14 |
) |
|
(2,801 |
) |
|
18 |
|
||||
Net loss and comprehensive loss |
|
(7,679 |
) |
|
(10,004 |
) |
|
(8,497 |
) |
|
(32,536 |
) |
||||
Deemed dividend |
|
- |
|
|
- |
|
|
661 |
|
|
- |
|
||||
Net loss available to common stockholders | $ |
(7,679 |
) |
$ |
(10,004 |
) |
$ |
(9,158 |
) |
$ |
(32,536 |
) |
||||
Net loss per common share: | ||||||||||||||||
Basic | $ |
(0.25 |
) |
$ |
(0.65 |
) |
$ |
(0.35 |
) |
$ |
(2.34 |
) |
||||
Diluted | $ |
(0.25 |
) |
$ |
(0.65 |
) |
$ |
(0.36 |
) |
$ |
(2.34 |
) |
||||
Weighted-average common shares outstanding: | ||||||||||||||||
Basic |
|
30,552,063 |
|
|
15,335,373 |
|
|
26,350,138 |
|
|
13,907,357 |
|
||||
Diluted |
|
30,552,063 |
|
|
15,335,373 |
|
|
26,411,020 |
|
|
13,907,357 |
|
Mobix Labs, Inc. | ||||||||||||||||
Reconciliation of Non-GAAP Financial Measures | ||||||||||||||||
(unaudited, in thousands) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Computation of Adjusted Loss from Operations: | ||||||||||||||||
GAAP loss from operations | $ |
(9,348 |
) |
$ |
(9,739 |
) |
$ |
(35,179 |
) |
$ |
(30,804 |
) |
||||
Depreciation |
|
127 |
|
|
112 |
|
|
357 |
|
|
337 |
|
||||
Amortization of acquisition related intangible assets |
|
481 |
|
|
210 |
|
|
1,117 |
|
|
631 |
|
||||
Merger & acquisition- related expenses |
|
976 |
|
|
27 |
|
|
3,491 |
|
|
71 |
|
||||
Inventory write-off |
|
- |
|
|
- |
|
|
125 |
|
|
- |
|
||||
Stock-based compensation expense |
|
3,622 |
|
|
4,752 |
|
|
17,768 |
|
|
14,387 |
|
||||
Adjusted loss from operations | $ |
(4,142 |
) |
$ |
(4,638 |
) |
$ |
(12,321 |
) |
$ |
(15,378 |
) |
||||
Three Months Ended | Nine Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
GAAP gross profit: | ||||||||||||||||
GAAP net revenue | $ |
2,058 |
|
$ |
80 |
|
$ |
3,488 |
|
$ |
791 |
|
||||
GAAP cost of revenue |
|
1,327 |
|
|
285 |
|
|
2,608 |
|
|
1,188 |
|
||||
GAAP gross profit | $ |
731 |
|
$ |
(205 |
) |
$ |
880 |
|
$ |
(397 |
) |
||||
GAAP gross margin % |
|
35.5 |
% |
|
-256.3 |
% |
|
25.2 |
% |
|
-50.2 |
% |
||||
Computation of Adjusted Gross Profit: | ||||||||||||||||
GAAP gross profit | $ |
731 |
|
$ |
(205 |
) |
$ |
880 |
|
$ |
(397 |
) |
||||
Amortization of acquisition-related intangible assets |
|
72 |
|
|
68 |
|
|
208 |
|
|
204 |
|
||||
Inventory write-off |
|
- |
|
|
- |
|
|
125 |
|
|
- |
|
||||
Stock-based compensation expense |
|
27 |
|
|
12 |
|
|
27 |
|
|
34 |
|
||||
Adjusted Gross Profit | $ |
830 |
|
$ |
(125 |
) |
$ |
1,240 |
|
$ |
(159 |
) |
||||
Adjusted Gross Margin % |
|
40.3 |
% |
|
-156.3 |
% |
|
35.6 |
% |
|
-20.1 |
% |
Mobix Labs, Inc. | ||||||||
Condensed Consolidated Balance Sheets | ||||||||
(unaudited, in thousands, except share and per share amounts) | ||||||||
June 30, | September 30, | |||||||
2024 |
2023 |
|||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash | $ |
205 |
|
$ |
89 |
|
||
Accounts receivable, net |
|
1,478 |
|
|
53 |
|
||
Inventory |
|
1,906 |
|
|
319 |
|
||
Prepaid expenses and other current assets |
|
481 |
|
|
369 |
|
||
Total current assets |
|
4,070 |
|
|
830 |
|
||
Property and equipment, net |
|
1,915 |
|
|
1,859 |
|
||
Intangible assets, net |
|
18,570 |
|
|
5,287 |
|
||
Goodwill |
|
15,206 |
|
|
5,217 |
|
||
Operating lease right-of-use assets |
|
1,086 |
|
|
1,030 |
|
||
Deferred transaction costs |
|
- |
|
|
4,125 |
|
||
Other assets |
|
430 |
|
|
400 |
|
||
Total assets | $ |
41,277 |
|
$ |
18,748 |
|
||
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK | ||||||||
AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||
Current liabilities | ||||||||
Accounts payable | $ |
10,572 |
|
$ |
8,995 |
|
||
Accrued expenses and other current liabilities |
|
8,839 |
|
|
4,519 |
|
||
Deferred purchase consideration |
|
2,466 |
|
|
- |
|
||
Notes payable |
|
723 |
|
|
1,286 |
|
||
Notes payable - related parties |
|
2,495 |
|
|
3,793 |
|
||
Simple agreements for future equity |
|
- |
|
|
1,512 |
|
||
Operating lease liabilities, current |
|
406 |
|
|
318 |
|
||
Total current liabilities |
|
25,501 |
|
|
20,423 |
|
||
Earnout liability |
|
2,960 |
|
|
- |
|
||
PIPE make-whole liability |
|
1,949 |
|
|
- |
|
||
Deferred tax liability |
|
361 |
|
|
86 |
|
||
Operating lease liabilities, noncurrent |
|
1,139 |
|
|
1,280 |
|
||
Other noncurrent liabilities |
|
831 |
|
|
- |
|
||
Total liabilities |
|
32,741 |
|
|
21,789 |
|
||
Redeemable convertible preferred stock |
|
- |
|
|
2,300 |
|
||
Stockholders' deficit | ||||||||
Common stock, $0.00001 par value |
|
- |
|
|
- |
|
||
Additional paid-in capital |
|
101,456 |
|
|
78,421 |
|
||
Accumulated deficit |
|
(92,920 |
) |
|
(83,762 |
) |
||
Total stockholders' equity (deficit) |
|
8,536 |
|
|
(5,341 |
) |
||
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) | $ |
41,277 |
|
$ |
18,748 |
|